Opening book details…
About this scholarly article
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan by Cleary, James M.; McRee, Autumn J.; Shapiro, Geoffrey I.; Tolaney, Sara M.; O’Neil, Bert H.; Kearns, Jeffrey D.; Mathews, Sara; Nering, Rachel; MacBeath, Gavin; Czibere, Akos; Sharma, Sunil; Korn, W. Michael is a scholarly article available to read on EtoBox.
- Author
- Cleary, James M.; McRee, Autumn J.; Shapiro, Geoffrey I.; Tolaney, Sara M.; O’Neil, Bert H.; Kearns, Jeffrey D.; Mathews, Sara; Nering, Rachel; MacBeath, Gavin; Czibere, Akos; Sharma, Sunil; Korn, W. Michael
- Publisher
- Springer US; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 0167-6997)
- Published
- 2017
- Language
- EN